Presenting our Non-additive, Next-Generation Antimicrobial Polymers for Medical Devices.
Dr. Emma Wrigglesworth, Technical Lead at Inhibit Coatings, will be presenting on our exciting new venture into antimicrobial medical polymers for medical devices. Her talk, titled “Non-additive, Next-Generation Antimicrobial Polymers for Medical Devices,” is scheduled for October 17th. It will be held from 3:45 PM to 4:15 PM Central Time in Meeting Room 102 F.
Moreover, medtech innovation is recognized as playing a vital role in improving patient outcomes. At Inhibit Coatings, it is believed that antimicrobial medical polymers can be produced at a fraction of current costs. In addition, the need for extra coatings could be eliminated, reducing the barriers to using antimicrobial medical devices.
Although medical devices are critical for patient care, they often provide a pathway for pathogens to enter the body. This typically happens when the immune system is already under stress. However, by using antimicrobial medical polymers, harmful pathogens can be prevented from taking hold. As a result, the risk of healthcare-associated infections (HAIs) could be significantly reduced. Currently, it is estimated that HAIs cause about 72,000 deaths annually in U.S. hospitals. It is hoped that this number can be drastically lowered through the use of these innovative polymers.
To learn more, inquiries are welcomed, and further information will be provided. It is encouraged that anyone interested reach out — we look forward to your engagement.
About MD&M Minneapolis
MD&M Minneapolis is scheduled to be held at the Minneapolis Convention Centre on October 16th and 17th, 2024. The event is designed to cover every phase of the product development cycle, from research to final execution. Additionally, key topics such as regulatory, security, and user experience considerations are addressed. Attendees will be introduced to new technologies, including our antimicrobial medical polymers, digital health innovations, and 3D printing.
Finally, this two-day event will be attended by medical manufacturers, thought leaders, and academics. Critical challenges in medtech, including cardiovascular treatment and robotics, will be collaboratively explored.
More information about MD&M Minneapolis can be found at their website Here.
